Hyperfine, Inc. Files 8-K Report
Ticker: HYPR · Form: 8-K · Filed: Jul 24, 2024 · CIK: 1833769
| Field | Detail |
|---|---|
| Company | Hyperfine, Inc. (HYPR) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, company-information
TL;DR
Hyperfine filed its 8-K. Nothing major disclosed, just standard reporting.
AI Summary
On July 24, 2024, Hyperfine, Inc. filed an 8-K report. The company, formerly known as HealthCor Catalio Acquisition Corp., is involved in the electromedical and electrotherapeutic apparatus industry. The filing does not disclose specific financial transactions or material events beyond its routine reporting status.
Why It Matters
This filing indicates Hyperfine, Inc. is meeting its regulatory reporting obligations. Investors should review the full filing for any specific disclosures that may impact the company's valuation or operations.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that suggests an immediate or significant risk.
Key Numbers
- 001-39949 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-1569027 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Hyperfine, Inc. (company) — Registrant
- HealthCor Catalio Acquisition Corp. (company) — Former name of Registrant
- 3845 (industry_code) — Standard Industrial Classification for Electromedical & Electrotherapeutic Apparatus
- 351 New Whitfield Street, Guilford, CT 06437 (address) — Principal Executive Offices
FAQ
What is the primary business of Hyperfine, Inc.?
Hyperfine, Inc. is classified under Standard Industrial Classification 3845, which pertains to Electromedical & Electrotherapeutic Apparatus.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 24, 2024.
What was Hyperfine, Inc.'s former name?
Hyperfine, Inc.'s former name was HealthCor Catalio Acquisition Corp.
Where are Hyperfine, Inc.'s principal executive offices located?
Hyperfine, Inc.'s principal executive offices are located at 351 New Whitfield Street, Guilford, Connecticut 06437.
What is the SEC file number for Hyperfine, Inc.?
The SEC file number for Hyperfine, Inc. is 001-39949.
Filing Stats: 480 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-07-24 16:15:39
Key Financial Figures
- $0.0001 — hich registered Class A common stock, $0.0001 par value per share HYPR The Nasdaq
- $1.00 — (the "Common Stock"), has fallen below $1.00 per share for 30 consecutive business d
Filing Documents
- hypr-20240724.htm (8-K) — 36KB
- 0000950170-24-086057.txt ( ) — 150KB
- hypr-20240724.xsd (EX-101.SCH) — 25KB
- hypr-20240724_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. As previously reported, on May 29, 2024, Hyperfine, Inc. (the "Company") received written notice (the "Notice") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, because the closing bid price for the Company's Class A common stock, par value $0.0001 per share (the "Common Stock"), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the "Bid Price Requirement"). On July 24, 2024, the Company received a letter from the Staff of Nasdaq indicating that it has regained compliance with the Bid Price Requirement and this matter is now closed.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HYPERFINE, INC. Date: July 24, 2024 By: /s/ Brett Hale Brett Hale Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary